Heather Rees - Net Worth and Insider Trading
Heather Rees Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Heather Rees owns 1 companies in total, including Atossa Therapeutics Inc (ATOS) .
Click here to see the complete history of Heather Rees’s form 4 insider trades.
Insider Ownership Summary of Heather Rees
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATOS | Atossa Therapeutics Inc | 2023-10-06 | SVP & Finance and Accounting |
Heather Rees Trading Performance
Heather Rees Ownership Network
Ownership Network List of Heather Rees
Ownership Network Relation of Heather Rees
Heather Rees Owned Company Details
What does Atossa Therapeutics Inc do?
Who are the key executives at Atossa Therapeutics Inc?
Heather Rees is the SVP & Finance and Accounting of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include CFO & General Counsel Kyle Guse , director & 10 percent owner & Chief Scientific Officer Shu-chih Chen , and director & 10 percent owner & CEO Steven C Quay .
Atossa Therapeutics Inc (ATOS) Insider Trades Summary
Over the past 18 months, Heather Rees made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .
In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atossa Therapeutics Inc Insider Transactions
Heather Rees Mailing Address
Above is the net worth, insider trading, and ownership report for Heather Rees. You might contact Heather Rees via mailing address: C/o Atossa Therapeutics, Inc., 107 Spring Street, Seattle Wa 98104.